# Specific PoC Testing of Coagulation in Patients Treated With DOAC 1

> **NCT02825394** · — · UNKNOWN · sponsor: **University Hospital Tuebingen** · enrollment: 160 (estimated)

## Conditions studied

- Anticoagulation With NOAC

## Interventions

- **OTHER:** anti-Xa activity point-of-care testing (aXa-POCT)
- **OTHER:** ecarin clotting time point-of-care testing (ECT-POCT)

## Key facts

- **NCT ID:** NCT02825394
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10-13
- **Primary completion:** 2021-03
- **Final completion:** 2021-07
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2020-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02825394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02825394, "Specific PoC Testing of Coagulation in Patients Treated With DOAC 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02825394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*